NuCana (NCNA) vs Redhill Biopharma (RDHL)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Redhill Biopharma is the larger company by market cap ($4.9 million vs $4.6 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Head-to-head
| Metric | NCNA | RDHL |
|---|---|---|
| Share price | $1.11 | $0.55 |
| Market cap | $4.62M | $4.89M |
| 1-day change | -2.54% | +16.20% |
| Forward P/E | — | 18.33 |
| EPS (TTM) | $0.00 | $0.00 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $6.40 | $2.14 |
| 52-week low | $0.948 | $0.4351 |
| Distance from 52-week high | -82.64% | -74.30% |
| Average volume | 123.99K | 1.81M |
| Shares outstanding | 4.16M | 8.89M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
NCNA vs RDHL FAQ
Which is bigger, NuCana or Redhill Biopharma?
Redhill Biopharma (RDHL) is larger, with a market capitalization of $4.89M compared with $4.62M for NuCana (NCNA).
Are NuCana and Redhill Biopharma in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.